RetinalGenix Technologies
OTC: RTGNApollo Beach, US · Founded 2017 · Delaware corporation
Founders & leadership
JK
Jerry KatzmanNamed on SEC filing
Board
VM
Vinay MehindruBoard director
HG
Herbert GouldBoard director
Reported raises · per SEC filings
Form D private placements$698.1K disclosed across 2 rounds · 2021–2024
▶$653.1KraisedFeb 2025 · 30 investors · BiotechnologyRule 506(b)
▶$653.1KraisedFeb 2025 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerry KatzmanExecutive Officer, Director
- Vinay MehindruDirector
- Herbert GouldDirector
- Offering amount
- $5M
- Amount sold
- $653.1K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45KraisedJul 2021 · 3 investors · Other Health CareRule 506(b)
▶$45KraisedJul 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- HERBERT GOULDDirector
- JERRY KATZMANExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $45K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
RetinalGenix Technologies | Asset Manager | Altssaltss.com · Aug 2026Frequently asked questions
- How much funding has RetinalGenix Technologies raised?
- RetinalGenix Technologies has disclosed $698.1K raised across 2 rounds.
- Where is RetinalGenix Technologies headquartered?
- RetinalGenix Technologies is headquartered in Apollo Beach, US.